| Primary |
| Hiv Infection |
72.9% |
| Drug Use For Unknown Indication |
12.1% |
| Product Used For Unknown Indication |
6.2% |
| Antiretroviral Therapy |
2.2% |
| Hepatitis C |
0.7% |
| Cerebral Toxoplasmosis |
0.6% |
| Depression |
0.6% |
| Prophylaxis |
0.6% |
| Antiviral Treatment |
0.5% |
| Hiv Infection Cdc Category A2 |
0.4% |
| Hypertension |
0.4% |
| Pulmonary Tuberculosis |
0.4% |
| Burkitt's Lymphoma |
0.4% |
| Hiv Test Positive |
0.4% |
| Tuberculosis |
0.3% |
| Antiviral Prophylaxis |
0.3% |
| Gout |
0.3% |
| Insomnia |
0.3% |
| Antibiotic Prophylaxis |
0.2% |
| Anxiety |
0.2% |
|
| Myocardial Infarction |
20.8% |
| Vomiting |
11.7% |
| Pyrexia |
6.7% |
| Rash |
6.7% |
| Microcephaly |
6.4% |
| Hepatotoxicity |
5.3% |
| Drug Exposure During Pregnancy |
4.6% |
| Rash Maculo-papular |
4.6% |
| Death |
4.2% |
| Weight Decreased |
3.5% |
| Acute Myocardial Infarction |
2.8% |
| Myositis |
2.8% |
| Tachycardia |
2.8% |
| Cerebrovascular Accident |
2.5% |
| Jaundice |
2.5% |
| Paraesthesia |
2.5% |
| Rash Generalised |
2.5% |
| Transaminases Increased |
2.5% |
| Virologic Failure |
2.5% |
| Hepatocellular Injury |
2.1% |
|
| Secondary |
| Hiv Infection |
58.8% |
| Product Used For Unknown Indication |
12.6% |
| Antiretroviral Therapy |
7.3% |
| Drug Use For Unknown Indication |
5.9% |
| Drug Exposure During Pregnancy |
5.1% |
| Prophylaxis Against Transplant Rejection |
1.7% |
| Antiviral Treatment |
1.2% |
| Acquired Immunodeficiency Syndrome |
1.0% |
| Hypertension |
0.9% |
| Prophylaxis |
0.8% |
| Maternal Exposure Timing Unspecified |
0.7% |
| Systemic Antiviral Treatment |
0.6% |
| Depression |
0.5% |
| Hiv Test Positive |
0.5% |
| Age-related Macular Degeneration |
0.5% |
| Hepatic Cirrhosis |
0.4% |
| Mycobacterium Avium Complex Infection |
0.4% |
| Tuberculosis |
0.4% |
| Opportunistic Infection Prophylaxis |
0.3% |
| Type 2 Diabetes Mellitus |
0.3% |
|
| Myocardial Infarction |
14.7% |
| Pregnancy |
10.9% |
| Normal Newborn |
8.4% |
| Vomiting |
7.4% |
| Rash Maculo-papular |
5.6% |
| Urine Colour Abnormal |
5.6% |
| Osteonecrosis |
4.9% |
| Rash |
4.2% |
| Pneumothorax |
3.9% |
| Pyrexia |
3.9% |
| Renal Failure Acute |
3.9% |
| Renal Colic |
3.5% |
| Hypertrophic Cardiomyopathy |
3.2% |
| Renal Failure |
3.2% |
| White Blood Cell Count Increased |
3.2% |
| Laboratory Test Abnormal |
2.8% |
| Microcephaly |
2.8% |
| Rhabdomyolysis |
2.8% |
| Weight Decreased |
2.8% |
| Pancreatitis Acute |
2.5% |
|
| Concomitant |
| Hiv Infection |
65.1% |
| Product Used For Unknown Indication |
8.2% |
| Drug Use For Unknown Indication |
6.7% |
| Hepatitis C |
3.6% |
| Hypertension |
2.8% |
| Acquired Immunodeficiency Syndrome |
1.5% |
| Antiretroviral Therapy |
1.5% |
| Drug Exposure During Pregnancy |
1.3% |
| Infection Prophylaxis |
1.2% |
| Prophylaxis |
1.0% |
| Transplant |
1.0% |
| Epilepsy |
0.9% |
| Septic Shock |
0.9% |
| Asthma |
0.7% |
| Cerebral Toxoplasmosis |
0.7% |
| Depression |
0.6% |
| Diabetes Mellitus |
0.6% |
| Castleman's Disease |
0.5% |
| Dyslipidaemia |
0.5% |
| Neuropathy Peripheral |
0.5% |
|
| Malnutrition |
11.4% |
| Renal Colic |
9.3% |
| Vomiting |
7.1% |
| Tubulointerstitial Nephritis |
6.4% |
| Pancytopenia |
5.7% |
| Rash |
5.7% |
| Renal Failure |
5.7% |
| Weight Decreased |
5.7% |
| Septic Shock |
5.0% |
| Thrombocytopenia |
4.3% |
| Weight Increased |
4.3% |
| Abortion Induced |
3.6% |
| Acute Myocardial Infarction |
3.6% |
| Oedema Peripheral |
3.6% |
| Off Label Use |
3.6% |
| Pain In Extremity |
3.6% |
| Blood Creatine Phosphokinase Increased |
2.9% |
| Cardiomyopathy |
2.9% |
| Haemarthrosis |
2.9% |
| Neuralgia |
2.9% |
|
| Interacting |
| Product Used For Unknown Indication |
32.9% |
| Hiv Infection |
21.9% |
| Pulmonary Tuberculosis |
13.7% |
| Antiviral Prophylaxis |
6.8% |
| Contraception |
4.1% |
| Hepatitis C |
4.1% |
| Liver Transplant |
4.1% |
| Chronic Hepatitis |
2.7% |
| Aggression |
1.4% |
| Anxiety |
1.4% |
| Depression |
1.4% |
| Phytotherapy |
1.4% |
| Pulmonary Embolism |
1.4% |
| Type 2 Diabetes Mellitus |
1.4% |
| Weight Decreased |
1.4% |
|
| Pregnancy With Implant Contraceptive |
18.2% |
| Vomiting |
18.2% |
| Abnormal Weight Gain |
9.1% |
| Ectopic Pregnancy |
9.1% |
| Lactic Acidosis |
9.1% |
| Puncture Site Haemorrhage |
9.1% |
| Sepsis |
9.1% |
| Urinary Tract Infection |
9.1% |
| White Blood Cell Count Increased |
9.1% |
|
